Need professional-grade analysis? Visit stockanalysis.com
$13.26B
72.50
2,843
1.43%
Sihuan Pharmaceutical Holdings Group Ltd (0460) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at HKD1.34, down 3.60% from the previous close.
Over the past year, 0460 has traded between a low of HKD0.65 and a high of HKD1.91. The stock has gained 107.6% over this period. It is currently 29.8% below its 52-week high.
Sihuan Pharmaceutical Holdings Group Ltd has a market capitalization of $13.26B, with a price-to-earnings ratio of 72.50 and a dividend yield of 1.43%.
Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People's Republic of China and the United States. It operates through three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The company offers filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care, and others, as well as non- or minimally invasive medical aesthetics comprehensive solutions. It also provides drugs in the oncology, metabolism, diabetes, cardiovascular and cerebrovascular, modern Chinese medicine, and industrial hemp therapeutic areas. In addition, the company involved in the provision of research and development, and industrialization of innovative medicine; construction for medical project; provision of general hospital services and hospital management services; and property investment business. Sihuan Pharmaceutical Holdings Group Ltd. was founded in 2001 and is based in Wan Chai, Hong Kong.
Side-by-side comparison against top Healthcare peers.